Press Releases 2016
Boston Scientific announces long-term data from the EVOLVE Trial of the SYNERGY™ Stent presented today at EuroPCR 2016 - May 19, 2016
Final, 5-year results from the EVOLVE Trial evaluating the Boston Scientific (NYSE: BSX) SYNERGY Stent support long-term safety and efficacy for the treatment of patients with de novo coronary artery disease...
Boston Scientific announces schedule of presentations at EuroPCR 2016 - May 13, 2016
Boston Scientific (NYSE: BSX) today announced its schedule of key data, including one late-breaking clinical trial, that will be featured at the ...
Media Contacts
Rosie Ireland
Corporate Communications
+44 7585403359
rosie.ireland@bsci.com